Article citationsMore>>

Yingling, J.M., McMillen, W.T., Yan, L., Huang, H., Scott Sawyer, J., Graff, J., et al. (2018) Preclinical Assessment of Galunisertib (LY2157299 Monohydrate), a First-in-Class Transforming Growth Factor-β Receptor Type I Inhibitor. Oncotarget, 9, 6659-6677.
https://doi.org/10.18632/oncotarget.23795

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top